(NP (NP (JJ Transcriptional) (NN control)) (PP (IN of) (NP (NP (JJ steroid-regulated) (NN apoptosis)) (PP (IN in) (NP (JJ murine) (NN thymoma) (NNS cells))))) (. .))
(S (NP-SBJ (NP (JJ Early) (NNS studies)) (PP (IN in) (NP (JJ murine) (NN T) (NN cell) (NNS lines)))) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-54 (NP (JJ transcriptional) (NN transactivation) (NNS functions)) (VP (VBN encoded) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NP (NP (NN glucocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN GR)) (-RRB- -RRB-))) (JJ N-terminal) (NN domain))))) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-54)) (PP (IN for) (NP (JJ glucocorticoid-mediated) (NN apoptosis)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (ADJP-TMP (RBR more) (JJ recent)) (NNS studies)) (PP (IN in) (NP (JJ human) (NN T) (NN cell) (NNS lines)))) (VP (VBP have) (VP (VBN suggested) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (DT the) (JJ N-terminal) (NN domain)) (VP (VBZ is) (RB not) (ADJP-PRD (JJ necessary) (PP (IN for) (NP (JJ steroid-regulated) (NN apoptosis))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (JJ GR-mediated) (NN transrepression)) (VP (MD may) (VP (VB be) (NP-PRD (DT the) (ADJP (RBR more) (JJ critical)) (NN mechanism))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-55)) (VP (TO To) (VP (ADVP (RBR better)) (VB understand) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (DT the) (NN GR) (JJ N-terminal) (NN transactivation) (NN domain))) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG mediating) (NP (JJ murine) (NN thymocyte) (NN apoptosis))))))))) (, ,) (NP-SBJ-55 (PRP we)) (ADVP (RB stably)) (VP (VBD transfected) (NP-COOD (NP (NN GR)) (, ,) (NP (NN GR) (NNS variants)) (, ,) (CC and) (NP (NP (DT the) (NN androgen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN AR)) (-RRB- -RRB-)))) (PP (IN into) (NP (JJ receptor-negative) (NN S49) (JJ murine) (NN thymoma) (NNS cells)))) (. .))
(S-COOD (S (NP-SBJ-57 (NN GR) (NN expression) (NNS levels)) (VP (VBD were) (VP (VBN shown) (S (NP-SBJ-58 (-NONE- *-57)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ rate-limiting)) (PP (IN for) (S (NP-SBJ (-NONE- *-58)) (VP (VBG initiating) (NP (DT the) (JJ apoptotic) (NN pathway))))))))))) (, ,) (CC and) (S (NP-SBJ-59 (NP (DT a) (JJ positive) (NN correlation)) (PP (IN between) (NP (NP-COOD (NP (NN steroid) (NN sensitivity)) (CC and) (NP (JJ GR-mediated) (NN induction))) (PP (IN of) (NP (DT an) (VBN integrated) (NP (NP (NN mouse) (JJ mammary) (NN tumor) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN MMTV)) (-RRB- -RRB-))) (NN LTR) (NN reporter) (NN gene)))))) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-59))))) (. .))
(S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (NP (NN GR) (JJ chimeric) (NNS receptors)) (VP (VBG containing) (NP (DT the) (JJ potent) (NP-COOD (NP (NN VP16)) (CC and) (NP (NN E1A))) (JJ viral) (NN transactivation) (NNS domains)) (PP (IN in) (NN place) (IN of) (NP (DT the) (NN GR) (NN N) (NN terminus))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ-60 (NP (RB even) (JJ low) (NN level) (NN expression)) (PP (IN of) (NP (DT these) (NNS receptors)))) (VP (VBD resulted) (PP (IN in) (NP-COOD (CC both) (NP (VBN enhanced) (NN steroid) (NN sensitivity)) (CC and) (NP (NN MMTV) (NN induction)))) (, ,) (S (NP-SBJ (-NONE- *-60)) (VP (ADVP (RB thus)) (VBG supporting) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NP (NN transactivation)) (PP (IN in) (NP (NN apoptosis)))))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NN AR)) (VP (MD can) (VP (VB initiate) (NP (NP (NN apoptosis)) (PP (IN in) (NP (NN S49) (NNS cells)))) (PP-TMP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (CD 5) (NN alpha-dihydrotestosterone))))) (, ,) (PP (IN despite) (NP (PRP$ its) (JJ relative) (NN inability) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB induce) (NP (NP (JJ high) (NN level) (NN expression)) (PP (IN of) (NP (NN MMTV)))))))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-61)) (VP (TO To) (VP (VB investigate) (NP (DT this)) (ADVP (RBR further))))) (, ,) (NP-SBJ-61 (PRP we)) (VP (VBD examined) (NP (NP (DT the) (JJ steroid-regulated) (NN expression)) (PP (IN of) (NP (NP (DT an) (JJ endogenous) (JJ thymocyte-specific) (NN gene)) (VP (VBN called) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN GIG18)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-62 (NN GIG18)) (VP (VBD was) (VP (ADVP-TMP (RB rapidly)) (VBN induced) (NP (-NONE- *-62)) (PP (TO to) (NP (JJ comparable) (NNS levels))) (PP (IN by) (NP-LGS-COOD (CC both) (NP (NN AR)) (CC and) (NP (NN GR)))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG demonstrating) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (NN AR)) (VP (MD can) (VP (ADVP (RB indeed)) (VB function) (PP (IN as) (NP (NP (DT a) (JJ transcriptional) (NN activator)) (PP (IN in) (NP (NN S49) (NNS cells))))))))) (CC and) (, ,) (RB moreover) (, ,) (SBAR (IN that) (S (NP-SBJ (NN GIG18) (NN induction)) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT a) (NN marker)) (PP (IN of) (NP (JJ early) (JJ apoptotic) (NNS events))) (PP (IN in) (NP (JJ steroid-treated) (NNS cells)))))))))))))))) (. .))
(S (S (NP-SBJ-64 (-NONE- *-102)) (VP (VBN Taken) (NP (-NONE- *-64)) (ADVP (RB together)))) (, ,) (NP-SBJ-102 (DT these) (NNS results)) (VP (VBP support) (NP (PRP$ our) (NN conclusion) (SBAR (IN that) (S (NP-SBJ (JJ transcriptional) (NN transactivation)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ necessary) (NN signaling) (NN component)) (PP (IN of) (NP (NN S49) (NN cell) (NN apoptosis)))))))) (, ,) (SBAR (IN although) (S (NP-SBJ-65 (NP (DT an) (JJ additional) (NN role)) (PP (IN for) (NP (JJ GR-mediated) (NN transrepression)))) (VP (MD can) (VP (RB not) (VP (VB be) (NP (-NONE- *-65)))))))) (VBN excluded))
